Enavate Sciences
North America, New York, United States, New York
Description
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies.
Investor Profile
Enavate Sciences has backed more than 15 startups, with 3 new investments in the last 12 months alone. The firm has led 10 rounds, about 67% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Biopharma, Therapeutics.
- Led 1 rounds in the past year.
Stage Focus
- Series B (47%)
- Series C (20%)
- Post Ipo Equity (13%)
- Series Unknown (7%)
- Series A (7%)
- Private Equity (7%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Biopharma
- Therapeutics
- Health Care
- Medical
- Pharmaceutical
- Life Science
- Genetics
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
